Cargando…

Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

Detalles Bibliográficos
Autores principales: Reichmann, Heinz, Lees, Andrew, Rocha, José-Francisco, Magalhães, Diogo, Soares-da-Silva, Patrício
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187493/
https://www.ncbi.nlm.nih.gov/pubmed/32345371
http://dx.doi.org/10.1186/s40035-020-00193-3
_version_ 1783527187281870848
author Reichmann, Heinz
Lees, Andrew
Rocha, José-Francisco
Magalhães, Diogo
Soares-da-Silva, Patrício
author_facet Reichmann, Heinz
Lees, Andrew
Rocha, José-Francisco
Magalhães, Diogo
Soares-da-Silva, Patrício
author_sort Reichmann, Heinz
collection PubMed
description
format Online
Article
Text
id pubmed-7187493
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71874932020-04-30 Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study Reichmann, Heinz Lees, Andrew Rocha, José-Francisco Magalhães, Diogo Soares-da-Silva, Patrício Transl Neurodegener Correction BioMed Central 2020-04-28 /pmc/articles/PMC7187493/ /pubmed/32345371 http://dx.doi.org/10.1186/s40035-020-00193-3 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Correction
Reichmann, Heinz
Lees, Andrew
Rocha, José-Francisco
Magalhães, Diogo
Soares-da-Silva, Patrício
Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
title Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
title_full Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
title_fullStr Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
title_full_unstemmed Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
title_short Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study
title_sort correction to: effectiveness and safety of opicapone in parkinson’s disease patients with motor fluctuations: the optipark open-label study
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187493/
https://www.ncbi.nlm.nih.gov/pubmed/32345371
http://dx.doi.org/10.1186/s40035-020-00193-3
work_keys_str_mv AT reichmannheinz correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy
AT leesandrew correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy
AT rochajosefrancisco correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy
AT magalhaesdiogo correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy
AT soaresdasilvapatricio correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy
AT correctiontoeffectivenessandsafetyofopicaponeinparkinsonsdiseasepatientswithmotorfluctuationstheoptiparkopenlabelstudy